Study: AstraZeneca Covid-19 Drug Neutralizes Sub-variants of Omicron
The pharmaceutical company ‘AstraZeneca’ said, the antibody-based cocktail of the company for the prevention and treatment of the novel corona virus had been showing to retain the neutralization activity against the Omicron corona virus variants that is including the highly contagious BA.2 sub variant of the Omicron in a study conducted by an independent lab. […]
Continue Reading